Sex differences in Alzheimer's disease (AD) phenotypes are well documented. Wang et al. examined sex-specific tau propagation across Braak neurofibrillary tangle stages in an Alzheimer's Disease Neuroimaging Initiative cohort, while considering cognitive and amyloid status, using longitudinal tau-PET imaging. They found that females exhibit faster tau spread and accelerated clinical decline in advanced stages. While the study offers valuable insights, factors such as neuroimaging-pathology discordance, coexisting conditions, and limited cohort diversity warrant caution before making broad generalizations. Nonetheless, these findings highlight sex-dependent AD trajectories and reinforce the need for precision medicine and timely, individualized interventions to improve outcomes and address biological variability in disease progression.
MakEKantarciKArvanitakisZ. Sex differences in in vivo biomarkers of neurodegenerative dementia. Front Dement2025; 4: 1706177.
2.
JosephsKA. Current understanding of neurodegenerative diseases associated with the protein tau. Mayo Clin Proc2017; 92: 1291–1303.
3.
WhitwellJLGraff-RadfordJTosakulwongN, et al.Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease. Alzheimers Dement2018; 14: 1005–1014.
4.
ShokouhiSTaylorWDAlbertK, et al.In vivo network models identify sex differences in the spread of tau pathology across the brain. Alzheimers Dement (Amst)2020; 12: e12016.
5.
WangXYeTDaiB, et al.Sex-specific patterns in tau spreading throughout the Braak stages in the Alzheimer's disease spectrum. J Alzheimers Dis2026; 109: 1153–1162.
6.
BoutinSHouzéBPichet BinetteA, et al.Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease. J Alzheimers Dis2026; 109: 203–223.
7.
MervoshNDeviG. Estrogen, menopause, and Alzheimer’s disease: understanding the link to cognitive decline in women. Front Mol Biosci2025; 12: 1634302.
8.
PriceBRWalkerKAEissmanJM, et al.Sex differences and the role of estrogens in the immunological underpinnings of Alzheimer's disease. Alzheimers Dement (N Y)2025; 11: e70139.
9.
WangYTTherriaultJTissotC, et al.Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females-evidence from two independent cohorts. Alzheimers Res Ther2024; 16: 162.
10.
Alvarez-de-la-RosaMSilvaINilsenJ, et al.Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann N Y Acad Sci2005; 1052: 210–224.
11.
TherriaultJBenedetALPascoalTA, et al.APOEepsilon4 potentiates the relationship between amyloid-beta and tau pathologies. Mol Psychiatry2021; 26: 5977–5988.
12.
SundermannEEMakiPMRubinLH, et al.Female advantage in verbal memory: evidence of sex-specific cognitive reserve. Neurology2016; 87: 1916–1924.
13.
GattoRGCarlosAFReichardRR, et al.Comparative assessment of regional tau distribution by tau-PET and post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients. PLoS One2023; 18: e0284182.
14.
GattoRGHossamYReichardRR, et al.Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions. Alzheimers Dement2024; 20: 8758–8768.
15.
YoussefHWeissmannCUrukG, et al.Looking into abnormal co-expressions of tau and TDP-43 in the realm of mixed dementia types: a double-punch scenario. Brain Sci2025; 15: 716.
16.
YoussefHGattoRGPhamNTT, et al.TDP-43 is associated with subiculum and cornu ammonis 1 hippocampal subfield atrophy in primary age-related tauopathy. J Alzheimers Dis2024; 99: 1023–1032.
17.
SubramaniapillaiSGaleaLAMEinsteinG, et al.Sex and gender in health research: intersectionality matters. Front Neuroendocrinol2024; 72: 101104.
18.
CornblathEJLiHLChangolkarL, et al.Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor. Sci Adv2021; 7: eabg6677.
19.
CoughlanGTKlingerHMBoyleR, et al.Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis. JAMA Neurol2025; 82: 364–375.
20.
FerrettiMTIulitaMFCavedoE, et al.Sex differences in Alzheimer disease — the gateway to precision medicine. Nat Rev Neurol2018; 14: 457–469.
